We have studied changes of epitopes on the haemagglutinin molecule (HA) of H1N1 influenza viruses isolated between 1977 and 1986. For this purpose monoclonal antibodies (MAbs) were raised against the HA of the influenza A/England/333/80 and A/Yamagata/120/86 strain viruses. In order to define the amino acid residues responsible for the change of epitopes, we prepared several HA cDNAs modified by site-directed mutagenesis and cloned them into a simian virus 40 expression vector (SVHA). The substitution of glycine with serine at position 125c (suffix indicates presence in H1 but not in H3 subtype HAs) on the HA of the influenza A/USSR/90/77 strain virus resulted in the loss of epitope l 10 (epitopes were named after MAbs) and created new epitopes 139 and 15, which were observed on the HA of A/England/333/80 and a few isolates from 1983. These new epitopes disappeared from the HA in some of the isolates in 1983 and most of the isolates in 1984 and 1986. The disappearance of epitopes 139 and 15 seems to be associated with the loss of epitope W18, which was identified on the HA of A/USSR/90/77. We suggested previously that amino acid residue 189 was involved in epitope W18. We therefore expressed an HA protein with two amino acid substitutions at positions 189 and 125c and found that the conversion of glutamine to lysine at position 189 in SVHA-67 prevented the expression of epitopes 139 and 15.
Introduction
Influenza A virus is peculiar in its capacity to change its antigenic phenotype with relative ease and thus evade neutralizing antibodies. This property has been ascribed to the accumulation of a series of amino acid changes in antigenically important regions of the haemagglutinin (HA) molecule. The molecular basis of the amino acid changes in the HA molecule during the evolution of H 1 N 1 and H3N2 influenza viruses has been analysed by determining the nucleotide sequences of the HA genes of field strains (Both & Sleigh, 1981; Both et al., 1983; Raymond et al., 1983 Raymond et al., , 1986 Nakajima et al., 1988; Cox et al., 1989) and by investigating antigenic characteristics of the HA molecule using monoclonal antibodies (MAbs) (Gerhard & Webster, 1978; Webster et al., 1979; Gerhard et al., 1981; Nakajima & Kendal, 1981; Underwood, 1982 Underwood, , 1984 Yamada et al., 1984) . The combination of such studies is useful in order to understand the molecular basis of antigenic changes. We have identified the binding sites of MAbs produced by t Present address: The Institute of Public Health, Tokyo 108, Japan. 0000-9632 © 1991 SGM Webster et al. (1979) against the HA of influenza A/USSR/90/77 (HIN1) strain virus (USSR/77) (Nakajima et al., 1983) , and have used an expression vector in combination with site-directed mutagenesis to identify unequivocally the amino acid residues constituting an epitope (Nobusawa et al., 1987) . As a result of progressive antigenic drift, most of the MAbs produced by Webster et al. (1979) against the HA of USSR/77 did not react with viruses isolated after 1983. In order to analyse any changes in the epitope(s), we isolated MAbs raised against the HA of A/England/333/80 (Eng/80) and A/Yamagata/120/86 (Yamagata/86). This paper describes changes in epitopes on the HA of H1N1 influenza viruses isolated between 1977 and 1986 analysed by a combination of serological tests and site-directed mutagenesis of HA genes, followed by expression in a simian virus 40 (SV40) vector. (Sugiura & Ueda, 1980) . Virus purification has been described previously (Nakajima et al., 1983) . We also used antigenic variants selected by MAbs against the HA of USSR/77, A-1-42, B-1-23, C-l-l, D-l-14 and E-l-1 (Nakajima & Kendal, 1981 ; Nakajima et al., 1983) .
Methods

Viruses and propagation.
Haemagglutination inhibitions (HI) tests. HI tests were done in microtitre plates against 4 haemagglutination units (HAU) using receptor-destroying enzyme-treated chicken sera and mouse MAbs (Dowdle et al., 1979) .
MAbs and chicken sera. Hybrid cell lines producing MAbs against the HA of Eng/80 and Yamagata/86 were prepared as described previously (Yamada et al., 1984) ; myeloma cells (X63-Ag8-6.5.3) were used as parental cells. Chicken antisera against influenza viruses were obtained as follows. On day 0, purified influenza viruses were injected intravenously (8000 HAU) and intramuscularly (2000 HAU) without adjuvant into the chicken and sera were collected 10 days later.
Competitive binding assay. The competitive binding assay was performed by a modified ELISA method (Kimura & Yasui, 1983) . Purified viruses at limiting concentration were used as antigen. Serial dilutions of each competing MAb from culture fluid were added to the Eng/80 virus-adsorbed wells in microplates; growth medium was used as a control. After being allowed to stand for 2 h at room temperature, the wells were washed and horseradish peroxidase (HRPO)-labelled MAbs, at a concentration yielding an absorbance of 1.0 at 490 nm, were added. The amount of competitive binding was estimated from the absorbance at 490 nm in the presence or absence of unlabelled competing antibodies. The percentage competition was determined by the formula [l 00(A-n)]/(A-B), where A is the absorbance in the absence of competing antibody, n is the absorbance in the presence of a competitor and B is the absorbance in the presence of homologous competing antibody. The greatest inhibition (B, 0.15 to 0.18) was produced by 104 ELISA units of homologous competing antibodies and, therefore, 104 ELISA units of unlabelled antibody was used as a competitor.
Expression of HA cDNA. The SV40 late replacement expression vector SVHA-2 contains a full-length cDNA copy of the HA gene of USSR/77; the SV40 late functions were provided by helper virus dl-1055, an SV40 early deletion mutant. CV-1 African green monkey kidney cells were used for expression of the HA gene from the SVHA recombinant virus as described previously (Nobusawa et al., 1987) .
Mutagenesis and recombinant DNAs. pSVHA-64 and -65 were prepared by site-directed mutagenesis using the M 13 phage system as described previously (Nobusawa et al., 1987) . pSVHA-66 was prepared by site-directed mutagenesis using the polymerase chain reaction (PCR). HA cDNA of USSR/77 was excised from pSVHA-2 (Nobusawa et al., 1987) with XbaI and BgllI and recloned into the pUC19 plasmid DNA XbalBamHI site. A mutant primer was hybridized to a HA cDNA-pUCI9 DNA template by incubation at 95 °C for 5 rain and then cooling at room temperature. The primertemplate was incubated for 30 min with 25 mM-dNTPs and the Klenow fragment (4 units/20 ~tl). The reaction mixture (a tenth of a volume) was used for the PCR (90 °C, 2 min; 55 °C, 2 min; 70 °C, 3 min; 30 cycles) using mutant primer and pUC19 universal primer. Resulting mutant HA cDNA was excised with SacI and AvalI, and then a three-molecule ligation was carried out using the amplified fragment, the AvalI-ClaI fragment of HA cDNA (pSVHA-2) and the SacI-ClaI fragment of pSVHA-2, pSVHA-67 was prepared by ligation of the XbaI-HaellI fragment of mutant HA cDNA from pSVHA-64, the HaelII-BgllI fragment of mutant HA cDNA from pSVHA-66 and the XbaI-BgllI fragment of pSVHA-2.
The mutant primers used in this study were 5' AAGGAAAGCT-CATGGC 3' for pSVHA-64, 5' TCTTCAAATTATCACAGG 3' for pSVHA-65 and 5' CTTTTGGTCCTTTAT 3' for pSVHA-66 (underlining shows a base altered when compared to that of the template sequence; amino acid substitutions at positions 125c, 208 and 189 were serine for arginine in pSVHA-64, histidine for asparagine in pSVHA-65 and lysine for glutamic acid in pSVHA-66, respectively).
Indirect immunofluorescence test.
Monolayers of CV-1 ceils were infected with each SVHA recombinant virus. At 72 h post-infection the infected cells were fixed with ethanol/acetone and indirect immunofluorescent staining with MAbs was done as described previously (Nobusawa et al., 1987) . MAbs against the HA of USSR/77 (264, W 18, 110 and 385 ) were kindly supplied by Dr R. G. Webster.
Results
Characteristics of MAbs raised aga&st Eng/80
Thirteen MAbs against the HA of Eng/80 virus (four of which were conjugated to HRPO, MAbs 30, 139, 15 and 5) were grouped by competitive binding assay (Table 1) . HRPO-labelled MAb 30 was blocked completely by group I and partially by group II antibodies ( 66 to 79 %); HRPO-labelled MAb 139 was blocked completely by group III and partially by group II antibodies (72 to 80%); HRPO-labelled MAb 15 was blocked completely only by itself (group IV); HRPO-labelled MAb 5 was blocked completely by group III, IV and V antibodies (86 to 100%), but not by group I and II antibodies. Thus, 13 MAbs against the HA of Eng/80 were divided into five groups. As shown in Table 2 , MAbs belonging to groups I, II and V recognized the HA of USSR/77 whereas 30  100  12  20  15  21  100  8  15  15  20  100  8  5  15  75  100  22  18  6  II  151  66  68  50  20  117  70  72  55  6  41  79  80  62  3  III  39  26  100  56  100  139  22  100  50  86  96  30  100  55  100  IV  15  35  40  100 Table 2 . MAbs belonging to groups I to V recognized different epitopes and groups III and IV recognized epitopes arising since 1980. Of the five MAbs raised against the HA of Yamagata/86, three reacted with the HA of USSR/77 whereas the other two had low HI activity and reacted only with the HA of Yamagata/86 and not other 1986 isolates (data not shown). Therefore we did not use them in the present study.
Antigenic and genetic changes of the HA of H1N1 influenza viruses during evolution
Antigenic differences were observed between the isolates obtained from 1977 to 1984 and the 1986 isolates when analysed by the HI test using chicken antisera (Table 3) . Yamagata/86 antiserum clearly distinguished viruses isolated in 1986 from those of 1984 and earlier whereas the distinction between viruses isolated at these two times using BK/83 and DUN/6/83 antisera was only twofold and therefore marginal (Table 3 ). Fig. 1 shows (1981) . Amino acids which were absent in H3 subtype HA were numbered using alphabetic suffixes (e.g. 125c). Published data for amino acid sequences of H1N1 influenza viruses were used (Nakajima et al., 1983; Concannon et al., 1984; Raymond et al., 1986; Robertson, 1987; Cox et al, 1989) except for the sequence of Yamagata/86 (S. Nakajima, K. Nakamura, F. Nishikawa & K. Nakajima, unpublished data). The amino acid at position 157 of the HA of USSR/77 virus was different in our sequence (Nakajima et al., 1983 ) when compared to those of Concanr~on et al. (1984) (lysine) and Raymond et al. (1986) (glutamic acid); we adopted our data.
an evolutionary tree of the H1N1 influenza viruses used in the present study. The amino acid sequences of the HA1 region of the HA, except that of Yamagata/86 (S. Nakajima, K. Nakamura, F. Nishikawa & K. Nakajima, unpublished data), have already been published (Nakajima et al., 1983; Concannon et al., 1984; Raymond et al., 1986; Cox et al., 1989) . The amino acid at position 157 of the HA of USSR/77 was different in our sequence (Nakajima et al., 1983 ) when compared to those of Concannon et al. (1984) (lysine) and Raymond et al. (1986) (glutamic acid); we adopted our data. The evolutionary tree shows that 1983 viruses were divided into two groups and that 1986 viruses derived from the branch of HK/32/83. Yamagata/86 was located on a branch derived from the same point of the stem as A/Taiwan/1/86 (Robertson, 1987) .
The fate of the epitopes on the HA1 protein of USSR/77
Antigenic characterization of the HIN1 influenza viruses with MAbs is shown in Table 2 . As reported previously, MAb 264 did not react with the HA of viruses isolated after 1978. This was due to the amino acid change at either position 189, from glutamic acid to lysine (Lackland/78), or position 219, from glutamic acid to lysine (Brazil/78) (Nakajima et al., 1983; Nobusawa et. al., 1987) . The latter change has been fixed as a mainstream change on the evolutionary tree after 1978. Viruses isolated after 1980 lost their reactivity to MAb 110 due to an amino acid change from arginine to serine at position 125c which became fixed as a mainstream change on the evolutionary tree (Fig. 1) . Different amino acid changes at position 125c (the suffix c indicates presence in H1 but not H3 subtype HAs) were also shown in USSR/77 variants D-l-14 (selected by MAb 110) and C-l-1 (selected by MAb W18), from arginine to lysine or glycine, respectively (Nakajima et al., 1983) . In order to clarify that the amino acid change from arginine to serine at position 125c was responsible for the loss of reactivity to MAb 110, we expressed a substituted HA protein from a mutated HA gene. SVHA-64 has one amino acid substitution at position 125c, of serine for arginine. The expressed HA protein of SVHA-64 reacted with either MAb 264 or MAb W18 but not with MAb 110 (Table 4) . Therefore, the amino acid change from arginine to serine at position 125c was shown to be responsible for the loss of the reactivity with MAb 110 of the HA of Eng/80. The amino acid change from glutamic acid to lysine at position 189 has been suggested to be responsible for the loss of reactivity with MAb W18 (Nakajima et al., 1983) . The same amino acid change was observed in field isolates (Lackland/78, Tex/82, HK/83 and DUN~27~83) and these viruses did not react with MAb W18. A different amino acid change at position 189 (glutamic acid to glycine) was observed in field isolates from 1986 and these viruses did not react with MAb W18 either ( Table 2 ). We have suggested that the amino acid change from glutamic acid to lysine at position 189 observed in Lackland/78 is responsible for the loss of reactivity with MAb W18 (Nobusawa et al., 1987) . However, other amino acid changes may also be responsible for the loss of reactivity with MAb W18 because the HA of DUN/6/83 had an unchanged amino acid at position 189 but did not react with MAb W 18. The amino acid change at position 225 in DUN/6/83 may not be responsible for the loss of the reactivity with MAb W18 because GA/83, which has the same amino acid change at position 225 as DUN/6/83, reacted with MAb W18 (Table 2) . Therefore, the amino acid change at position 129 or 192 was thought to play a role in the loss of reactivity to MAb W18. The isolates from 1986 had an amino acid change at position 189 and also two other suspected amino acid changes at positions 129 and 192.
Identification of new epitopes 139 and 15
In order to identify the antigenic determinant sites of new epitopes 139 and 15 we compared the amino acid (Table 4) . Two antigenic variants of USSR/77 (C-1-1 and D-1-14), which had the amino acid iysine or glycine at position 125c, did not react with MAbs 139 and 15 (Table 5) . Therefore, epitopes 139 and 15 were created by one amino acid substitution of serine for arginine at position 125c but these two epitopes were not identical, as shown in Tables 1 and 2 .
Disappearance of epitopes 139 and 15
Eng/80-1ike viruses were the major epidemic viruses during the period 1980 to 1982 but since then several different antigenic variants have appeared and epitopes W18, 139 and 15 have disappeared (Table 2 ). An antigenic variant of MAb W18 (C-l-I) had the amino acid at position 189 changed from glutamic acid to lysine. We expressed an HA with two amino acid substitutions from a mutant HA gene. SVHA-67 had two amino acid substitutions of serine for arginine and lysine for glutamic acid at residues 125c and 189 respectively. This HA did not react with MAbs 139, 15 and W 18 and it was shown that the amino acid substitution of lysine for glutamine at position 189 was reponsible for the disappearance of epitopes 139 and 15 (Table 4) . 
The estimation of reactivity is determined by immunofluorescent staining.
Discussion
In order to understand and control epidemics of influenza, extensive study of the characteristics of the antigenic change of influenza virus HA molecules during evolution is required. The antigenic determinants on the HA molecule of influenza A viruses have been studied extensively and four or five immunodominant antigenic regions on the proposed three-dimensional structure of the HA molecule have been defined in the H3 and H1 subtypes Wilson et al., 1981 ; Caton et al., 1982; Underwood, 1982 Underwood, , 1984 Daniels et al., 1983; Webster et al., 1983) . We found that the change in epitope 264 was the major reason for the antigenic drift from USSR/77-1ike to Brazil/78-1ike viruses (Nakajima & Kendal, 1981 ; Nobusawa et al., 1987) . We developed a method combining site-directed mutagenesis and an expression system to detect the amino acid residues determining an epitope. In this paper, we have studied the relationships between the amino acid changes and the changes of epitopes which were recognized by MAbs during the evolution of recent H 1N 1 influenza viruses. An amino acid change at an antigenic determinant site may alter the antigenic structure, resulting in the loss of an epitope(s) and the creation of a new epitope(s); the amino acid change at position 125c destroyed epitope 110 and created epitopes 139 and 15. However, the type of change in the amino acid is important in altering the antigenic structure (Table 5 ). The amino acid change from arginine to glycine at position 125c had no effect on epitope 110, whereas the change from arginine to serine or lysine caused alteration of the structure of epitope 110. The serine at position 125c was responsible for the creation of the new epitopes 139 and 15, whereas lysine at position 125c was not. It is interesting that both arginine and lysine are basic amino acids and that glycine and serine are similar in size. Amino acid substitutions between arginine and lysine or glycine and serine are believed to be conservative (Dayhoff et al., 1978) . However, the substitution of amino acids at position 125c with these similar amino acids altered the structure of the epitope.
Since 1986, many amino acid substitutions have occurred in the HA molecule and the amino acid residues corresponding to the epitopes mentioned above have changed. Analysis of new HA epitopes in isolates obtained after 1986 remains to be done.
In the present study we did not use a large panel of MAbs against the HA proteins of the H1N1 influenza viruses. Therefore our analysis of the alteration of the epitopes on the HA molecule was limited. However, the characterization of antigenic variants by site-directed mutagenesis in combination with an expression system is useful in the identification of amino acid residues responsible for the alteration of epitopes and contributes to the analysis of antigenic drift.
